Microbot Medical
MBOT
29 hedge funds and large institutions have $6M invested in Microbot Medical in 2021 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 3 closing their positions.
133% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 3
16% more funds holding
Funds holding: 25 → 29 (+4)
0.56% less ownership
Funds ownership: 11.18% → 10.62% (-0.56%)
11% less capital invested
Capital invested by funds: $6.77M → $6M (-$771K)
20% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
+$403K |
| 2 |
Renaissance Technologies
New York
|
+$303K |
| 3 |
State Street
Boston,
Massachusetts
|
+$260K |
| 4 |
Morgan Stanley
New York
|
+$11.3K |
| 5 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$7.55K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
XI
XXEC Inc
Tulsa,
Oklahoma
|
-$788K |
| 2 |
BlackRock
New York
|
-$420K |
| 3 |
Millennium Management
New York
|
-$96K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$47.6K |
| 5 |
Barclays
London,
United Kingdom
|
-$21.3K |
MBOT Hedge Fund Activity: Q2 2021 in Review
29 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q2 2021, worth a combined $6M — down 11% from $6.77M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new MBOT positions and 3 closed out — a net gain of 4 holders — while 4 added to existing stakes and 5 trimmed.
The largest buyer was Dimensional Fund Advisors, opening a new position worth an estimated $403K. The largest seller was XXEC Inc, exiting entirely with an estimated $788K sold.
- 29 institutional investors held Microbot Medical (MBOT) as of Q2 2021, up from 25 in Q1 2021.
- Funds reported $6M of Microbot Medical stock for Q2 2021, down 11% quarter-over-quarter.
- 7 funds opened new Microbot Medical positions in Q2 2021 and 3 closed out, a net change of +4 holders.
- The largest Microbot Medical buyer in Q2 2021 was Dimensional Fund Advisors, an estimated $403K added.
- The largest Microbot Medical seller in Q2 2021 was XXEC Inc, an estimated $788K sold.
Based on aggregated 13F filings for Q2 2021.